|
DNA Mismatch repair and cancer in murine models
|
5R01CA076329-21
|
$380,585
|
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Develop and Apply a Novel Genome-wide Mendelian Randomization Method to Examine Relationship between Obesity and Lung Cancer
|
5R21CA202529-02
|
$208,405
|
|
WANG, TAO
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Risk Prediction for ER Negative Breast Cancer Recurrence
|
5R01CA172511-05
|
$593,132
|
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer
|
1R01CA211176-01
|
$362,569
|
|
ELSEA, SARAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
4P01CA094237-14
|
$1,932,287
|
$483,072
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
ENHANCING T CELL THERAPY OF CANCER
|
5P01CA094237-15
|
$1,932,287
|
$483,072
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
5R01CA164024-05
|
$319,474
|
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
|
2R01CA116548-11A1
|
$249,637
|
$249,637
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$8,261
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$11,963
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$8,321
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$34,996
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$9,395
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$227,718
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
5R01CA174808-03
|
$326,348
|
$326,348
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel miR-198 replacement therapy for pancreatic cancer
|
5R01CA183984-03
|
$473,915
|
|
YAO, QIZHI
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
3R01CA166749-04S1
|
$13,734
|
$13,734
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
4R01CA166749-04
|
$318,913
|
$318,913
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Complex Role of HSF1 in Breast Cancer
|
5R01CA176326-04
|
$355,719
|
|
CALDERWOOD, STUART
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-07
|
$465,791
|
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
High resolution phase contrast endoscopy
|
5R01CA182939-04
|
$345,234
|
|
MERTZ, JEROME
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI
|
5R01CA160902-06
|
$220,860
|
|
MAIER, STEPHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
5R01CA170023-05
|
$393,163
|
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Impact of social and built environments on health-related quality of life for cancer survivors
|
5R03CA202192-02
|
$74,500
|
|
SHARIFF-MARCO, SALMA
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Diet-Associated Gut Microbiome Signatures and Risk of Colon Adenoma
|
1R03CA212558-01
|
$79,250
|
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcoma
|
5R01CA193677-02
|
$362,569
|
|
SCACHERI, PETER
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Diagnosis and longitudinal monitoring of metastatic prostate cancer through molecular MR imaging
|
5R01CA202814-02
|
$394,519
|
|
STEINMETZ, NICOLE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-03S1
|
$3,025,319
|
$242,026
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-03
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-03
|
$21,084,883
|
$1,686,791
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Structural Variation in Neuroblastoma
|
1R01CA204974-01A1
|
$384,300
|
$384,300
|
DISKIN, SHARON
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Altered mitochondria-ER signaling as a cause of chemotherapy resistance
|
1R21CA198430-01A1
|
$193,314
|
$193,314
|
HOGARTY, MICHAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
4R01CA124709-09
|
$614,290
|
$614,290
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Role of LMO1 in Neuroblastoma Initiation and Maintenance
|
5R01CA180692-02
|
$606,838
|
$606,838
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Pediatric Preclinical Testing Consortium
|
5U01CA199287-02
|
$357,000
|
$357,000
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-08
|
$374,344
|
$374,344
|
MOSSE, YAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblastoma
|
1K08CA194162-01A1
|
$168,264
|
$168,264
|
SCHNEPP, ROBERT
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Exploring the oncogenic potential of human APOBEC3 cytosine deaminases
|
5R21CA185799-02
|
$219,240
|
$74,542
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
5R01CA182633-03
|
$665,155
|
$665,155
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Training Physician Scientists in Pediatric Oncology
|
2T32CA009659-21A1
|
$64,768
|
$32,384
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
4R01CA129377-09
|
$239,246
|
$239,246
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Automated Ecological Video Identification of Physical Activity (E-VIP) Software
|
5R21CA194492-02
|
$152,937
|
|
CARLSON, JORDAN
|
CHILDREN'S MERCY HOSP (KANSAS CITY, MO)
|
|
Effect of different MRgHIFU approaches on anti-tumor responses
|
5R03CA201918-02
|
$78,000
|
|
JANSSEN, EDITH
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Role of MIF in myeloma bone homing and drug response
|
1R01CA211073-01
|
$362,569
|
|
YI, QING
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer
|
5F32CA180717-03
|
$63,078
|
|
HWANG, CHANG-IL
|
COLD SPRING HARBOR LABORATORY
|
|
Exercise, Breast Cancer Prevention and Mechanisms
|
5R01CA100693-12
|
$247,214
|
|
THOMPSON, HENRY
|
COLORADO STATE UNIVERSITY
|
|
Systems Biology of Tumor Progression and Drug Resistance
|
4U01CA168426-05
|
$1,238,106
|
$1,238,106
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$4,800
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$2,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$4,875
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Neuroblastoma for this search: $20,442,836
|